Boston, MA, based Investment company Omega Fund Management (US) Inc. (Current Portfolio) buys Morphic Holding Inc during the 3-months ended 2019Q4, according to the most recent filings of the investment company, Omega Fund Management (US) Inc.. As of 2019Q4, Omega Fund Management (US) Inc. owns 13 stocks with a total value of $309 million. These are the details of the buys and sells.
Here is the complete portfolio of Omega Fund Management (US) Inc.. Also check out:
1. Omega Fund Management (US) Inc.'s Undervalued Stocks
2. Omega Fund Management (US) Inc.'s Top Growth Companies, and
3. Omega Fund Management (US) Inc.'s High Yield stocks
4. Stocks that Omega Fund Management (US) Inc. keeps buying
For the details of Omega Fund Management (US) Inc.'s stock buys and sells, go to https://www.gurufocus.com/guru/omega+fund+management+%28us%29+inc./current-portfolio/portfolio
These are the top 5 holdings of Omega Fund Management (US) Inc.- Gossamer Bio Inc (GOSS) - 6,119,345 shares, 30.91% of the total portfolio. Shares reduced by 6.62%
- Replimune Group Inc (REPL) - 5,323,455 shares, 24.61% of the total portfolio. Shares added by 4.31%
- Morphic Holding Inc (MORF) - 2,969,582 shares, 16.47% of the total portfolio. New Position
- Translate Bio Inc (TBIO) - 2,437,603 shares, 6.41% of the total portfolio.
- Immunic Inc (IMUX) - 1,371,494 shares, 4.30% of the total portfolio.
Omega Fund Management (US) Inc. initiated holding in Morphic Holding Inc. The purchase prices were between $13.02 and $19.5, with an estimated average price of $15.61. The stock is now traded at around $17.20. The impact to a portfolio due to this purchase was 16.47%. The holding were 2,969,582 shares as of .
Here is the complete portfolio of Omega Fund Management (US) Inc.. Also check out:
1. Omega Fund Management (US) Inc.'s Undervalued Stocks
2. Omega Fund Management (US) Inc.'s Top Growth Companies, and
3. Omega Fund Management (US) Inc.'s High Yield stocks
4. Stocks that Omega Fund Management (US) Inc. keeps buying
